VE (nerve agent)
VE (nerve agent)[edit | edit source]
VE is a nerve agent belonging to the V-series nerve agents, which are a group of highly toxic chemical warfare agents. These agents are similar in structure and mechanism to the more widely known VX nerve agent. VE is an organophosphorus compound that inhibits the enzyme acetylcholinesterase, leading to an accumulation of acetylcholine in the synaptic cleft and causing continuous stimulation of muscles, glands, and central nervous system functions.
Chemical properties[edit | edit source]
VE is a phosphonate ester, characterized by the presence of a phosphorus atom bonded to an alkoxy group and a thioether group. The chemical structure of VE is similar to other V-series agents, with variations in the alkyl and alkoxy groups that influence its volatility, solubility, and toxicity.
Mechanism of action[edit | edit source]
VE acts by irreversibly binding to the active site of acetylcholinesterase, an enzyme responsible for breaking down acetylcholine in the synaptic cleft. This inhibition leads to an accumulation of acetylcholine, resulting in prolonged activation of cholinergic receptors. The overstimulation of these receptors causes muscle paralysis, respiratory failure, and potentially death if not treated promptly.
Symptoms of exposure[edit | edit source]
Exposure to VE can occur through inhalation, skin contact, or ingestion. Symptoms of exposure include:
- Miosis (constricted pupils)
- Rhinorrhea (runny nose)
- Bronchorrhea (excessive bronchial secretions)
- Muscle twitching and fasciculations
- Convulsions
- Respiratory distress
- Loss of consciousness
Treatment[edit | edit source]
The primary treatment for VE exposure involves the administration of atropine, an anticholinergic drug that blocks the effects of acetylcholine at muscarinic receptors, and pralidoxime, which can reactivate acetylcholinesterase if administered soon after exposure. Supportive care, including mechanical ventilation, may be necessary to manage respiratory failure.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD